Skip to content

Lack of Awareness of Symptoms (Anosognosia) in PD: An Observational Study for People With Parkinson's

Lack of Awareness of Symptoms (Anosognosia) in PD: An Observational Study to Examine the Effects of Anosognosia on Self-Reported Quality of Life for People With Parkinson's

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02561715
Enrollment
0
Registered
2015-09-28
Start date
2015-08-01
Completion date
2019-07-18
Last updated
2020-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anosognosia, Parkinson's

Keywords

Parkinson's, Anosognosia, DBS, Deep Brain Surgery

Brief summary

Anosognosia is a recognised condition for people with Parkinson's, and is the result of physiological damage on brain structure. Surgical Parkinson Disease Nurse Specialists have noticed that when reviewing the pre-surgery videos 12 months post-DBS, patients have forgotten and are shocked at how bad their symptoms were prior to surgery (personal communication), which may not be reflected in the change in QoL reported. This lack of awareness, while possibly helpful in everyday life, may lead to effective treatments looking ineffective, or the benefits in QoL of effective treatment appearing reduced. This confound may not only reduce the apparent effectiveness but also the related cost-effectiveness of treatment. As cost-effectiveness is determined by both size and longevity of an effect, current methods of capturing these data may be suboptimal.

Detailed description

The overarching aim of this project is to identify coping mechanisms and pathological lack of self-awareness and the impact they are likely to have on patient reported quality of life (QoL) outcome measures for a chronic condition. This will be an observational study, a case series of approx. 10 to 20 patients. These patients will be recruited over a 6 month period from the Queen Elizabeth Hospital, Birmingham and will be informed of the study during their routine pre-surgical visit. Patients will be eligible if they are about to undergo DBS at Queen Elizabeth Hospital. If the participant has a carer, who is also willing to participate, they may also join the study. Patients will be excluded if they are unable to complete questionnaires in English. Once recruited and following consent, a patient will complete a brief battery of questionnaires both self-reported and clinician rated prior to surgery and at their 6 month post op visit.

Interventions

BEHAVIORALQuestionnaires

Pre and post deep brain surgery questionnaires

Sponsors

University of Birmingham
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of Parkinson's as defined by the UK PDS Brain Bank Criteria

Exclusion criteria

* Unable to complete questionnaires in English.

Design outcomes

Primary

MeasureTime frameDescription
Improvement of ability to recall extent of condition9 monthsPerson with Parkinson's specific quality of life using the Parkinson's Disease Questionnaire for both participant and carer.

Secondary

MeasureTime frameDescription
Patient Generated Index9 monthsQuality of life measure
Abnormal Involuntary Movement Scale9 monthsOccurrence of tardive dyskinesia
Patient Competency Rating Scale9 monthsEvaluation of self-awareness following traumatic brain injury
Grooved peg board test9 monthsMeasuring motor performance
Clinician's Rating Scale for Evaluating Impaired Self Awareness and Denial of Disability after Brain Injury adapted for use with PD patients.after Brain Injury, adapted for use with Parkinson's Disease patients9 monthsParticipants self-awareness of their Parkinson's
Unified Parkinson's Disease Rating Scale9 monthsRating the extent of the participant's Parkinson's
Mini Mental State Exam9 monthsMeasure of cognitive impairment
Parkinson's' Disease Questionnaire9 monthsPDQ-39 (Carer)
The tapping test9 monthsMeasuring motor control

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026